Home > Healthcare > Medical Devices > Diagnostic Devices > Reproductive Toxicity Testing Market

Reproductive Toxicity Testing Market Trends

  • Report ID: GMI6668
  • Published Date: Sep 2023
  • Report Format: PDF

Reproductive Toxicity Testing Market Trends

Continuous advancements in testing methods have transformed reproductive toxicity assessments. Traditional animal testing is being supplemented and, in some cases, replaced by more ethical, cost-effective, and predictive models. For instance, in vitro assays, organ-on-a-chip technology, and computer-based modelling (In-silico) are some of the innovative methods contributing to more accurate and efficient testing. Thus, these advancements not only enhance the precision of reproductive toxicity testing but also reduce the reliance on animal models, aligning with ethical and regulatory concerns.
 

Additionally, pharmacogenomics modifies drug treatments to genetic profiles, and its significance in healthcare is on the rise. Reproductive toxicity testing ensures the safe use of genetically modified medications, thereby enhancing patient safety and supporting the growth of pharmacogenomic therapies.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Reproductive toxicity testing industry size was USD 10.6 billion in 2022 and will reach USD 25.7 billion by 2032 due to increasing demand for safety assessments in pharmaceuticals and chemicals, driven by stricter regulations worldwide.

The consumables product segment recorded USD 4.3 billion in 2022 and will register commendable CAGR from 2023-2032 on account of their indispensable role in conducting reproductive toxicity tests across various industries.

U.S. reproductive toxicity testing market size reached USD 4 billion in 2022 and will witness commendable growth rate from 2023-2032 owing to the presence of stringent regulatory requirements and the growing emphasis on safety assessment in the region.

Thermo Fisher Scientific, Inc., Charles River Laboratories International, Laboratory Corporation of America Holdings, Eurofins Scientific, Jubilant Life Sciences Limited, Syngene International Limited, and Gentronix Ltd. are some of the major reproductive toxicity testing companies worldwide.

Reproductive Toxicity Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 422
  • Countries covered: 30
  • Pages: 296
 Download Free Sample